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Quantitative estimations of skin glycogen
have been done by several investigators dur-
ing the past 50 years (1, 2). However, except
for the work of Adachi (3) in dog skin there
are no studies of the metabolism of skin
glycogen or epidermal glycogen.
Histochemical studies of epidermal glycogen
have been reported (4, 5). These histochemical
observations of normal, diseased, and experi-
mentally damaged skin have stimulated inter-
est in the changes which may occur in epider-
mal glycogen concentration.
Glycogen has been demonstrated histochem-
ically in fetal epidermis even before the liver
has begun to store glycogen. By the sixth fetal
month, however, glycogen has disappeared from
the epidermis (6) and is not found in the nor-
mal adult epidermis.
Under conditions of inflammation or abnor-
mal proliferation, epidermal glycogen reap-
pears. Minor epidermal trauma, such as strip-
ping off the stratum corneum with scotch
tape or exposure to ultraviolet light, will cause
a transitory reappearance of epidermal glyco-
gen. Similarly, dermal injury, such as a knife
cut, will stimulate the reappearance of epi-
dermal glycogen (5).
These histochemical demonstrations of the
appearance and disappearance of epidermal
glycogen must have related biochemical
changes. An explanation of these biochemical
changes and of the factors which control them
may yield valuable information concerning
epidermal metabolism and the mechanism in-
volved in the epidermal response to injury.
The purpose of this study was the quantita-
tive analysis of the enzymes and substrates in-
volved in the formation and breakdown of
glycogen in normal human epidermis.
List of Abbreviations and Definitiins
TRIS —Tris (hydroxymethyl)amino meth-
ane
—Ethylenediaminetetracetate
—Triphosphopyridine nucleotide
(NADP)
—Triphosphopyridine nucleotide in
reduced form (NADPII)
DPN
—.Diphosphopyridine nucleotide
(NAD)
DPNH —Diphosphopyridine nucleotide in
reduced form (NADH)
6-PG
—6-phosphogluconate
G-6-P
—Glucose-6-phosphate
G-i-P
—Glucose-i-phosphateilK
—hexokinase
PGM
—phosphoglucomutase
G-6-P DII —glucose-6-phosphate dehydrogenase
UDPG Dil—uridine diphosphoglucose dehydro-
genase
PK
—pyruvic kinase
LDH
—lactic dehydrogenase
P-ase
—phosphorylase
UDPG-PP —uridine diphosphoglucose pyrophos-
MATERIAIi
Human male volunteers aged 21—25 years were
used. Epidermis from the upper back was obtained
after the skin was prepared with alcohol. Strips of
epidermis approximately 3" by 1" (weighing about
50 mg wet) were removed without anesthesia by
means of an electric keratome set to cut at a depth
of 0.16—0.20 mm. One to five strips were removed
at one time. The epidermal strips which were to
be used for enzyme assays were weighed, and ho-
mogenized in .05M tris buffer pH 7.4 containing
.003M magnesium chloride and .0005 M EDTA.
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phorylase
—glycogen synthetase
—adenosine-fi-triphosphate
—adenosine-5-monophosphate
—adenosine-5-diphosphate
—phosphoenol pyruvate
—uridine diphosphoglucose
—uridine-5-triphosphate
—uridine-5-diphosphate
—millimicromoles (10—9 moles)
—micromoles (10 moles)
1 enzyme unit is equivalent to that amount of
enzyme which removes or "turns over" one micro-
mole of substrate per minute at pH 7.4 and 25° C.
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The strips for substrate assays were immediately
frozen in liquid nitrogen. Before assay, they were
weighed (frozen), and homogenized in 0.6 M per-
chioric acid. The perchlorie acid was neutralized
with 2N potassium hydroxide and the sample was
then centrifuged for 15 minutes at 3000 X g. The
neutral supernatant is referred to as the "acid ex-
tract."
The depth of the slice removed by the keratome
was of some importance since some dermal papillae
were included in the epidermal slices. The kera-
tome which was used has been amply described by
Blank et al (7). This instrument will remove pure
epidermis when set to cut at a depth of 0.1 mm.
This can only be achieved, however, by use of a
narrow blade. Much wider strips are easily re-
moved when the thickness of the epidermal strip
is from 0.16 mm to 020 mm. These depths are
achieved by the use of thin metal spacers. Dermal
contamination may vary from 5% to 20% with the
0.2 mm spacer when checked by histologic section.
This is quite variable, however, within a single
strip.
This small amount of dermal contamination
probably does not contribute significantly to the
glycogen metabolism reported here, although it
may be of some importance in studies of muco-
polysaccharide metabolism which is active in the
dermis. The epidermal slice which is removed is
bloodless, translucent, and easily floated on the
surface of any liquid media.
METHODS
The substrates and enzymes have been meas-
ured with a fluorometric method.* The analytic
procedure measured the formation or disappear-
ance of reduced triphosphopyridine nucleotide
(TPNH) or of reduced diphosphopyridine nucleo-
tide (DPNH), both of which are co-factors in
many biochemical reactions. These compounds ab-
sorb ultraviolet light at approximately 340 m
wave length and fluoresce at approximately 460
m after irradiation with the 340 m ultraviolet
light. The amount of absorption at 340 m or
fluorescence at 460 mL is directly proportional to
the concentration of DPNH or TPNII in the so-S
lution being assayed. The oxidized forms of these
compounds do not absorb or fluoresce.
The 360 m wave lengths from a Mercury lamp
are passed through the tube containing the reac-
tion mixture. Fluorescent light which is emitted
at right angles to the incident exciting light is
passed through a set of filters (maximal transmis-
sion at 460 m) to the phototube. The tube re-
sponse is amplified and measured by means of the
microammeter. The amplified signal from the
microammeter is then fed into the recorder to give
a permanent and continuous recording of the re-
action.
Another advantage of this method is that the
reaction can be monitored as it occurs to yield a
direct reading of the initial reaction velocity. This
velocity reflects most accurately the maximum at-
tainable velocity for the particular substrate and
enzyme concentration and is used in studies of
enzyme kinetics. Reaction velocities which are
measured later in the reaction may give low val-
ues due to accumulation of inhibitory products.
The following enzymes were studied in these
epidermal homogenates: hexokinase; phosphoglu-
comutase; glucose-6-phosphate dehydrogenase;
uridine diphosphoglucose-pyrophosphorylase;
UDPG dehydrogenase; glycogen synthetase, and
phosphorylase. The following substrates were
studied: glucose; glucose-6-phosphate; glucose-i-
phosphate; uridine diphosphoglucose; ATP, and
glycogen. The methods for each of these enzymes
and substrates are given below in Table I.
The substances to be assayed are listed in the
top column of this table. Epidermal homogenates
and "acid extracts" were made up to contain 1 mg
of fresh epidermis in 10 microliters (id) of sample.
This quantity of epidermal homogenate or "acid
extract" was added to 1 cc of tris buffer contain-
ing 0.003 M Mg Cli and 0.0005M EDTA. The sub-
stances which were also added to make up the
complete reaction mixture are indicated in the rest
of the table. Additional information on the indi-
vidual assays are as follows:
(1) Glucose-6-phozphate dehydrogenase (G-6-P
DII): 10 1d of epidermal homogenate are added to
1 cc of buffer and the fluorescence reading is al-
lowed to stabilize. 10 d (0.1 urn) TPN are then
added. After stability has been reached, 10 d of
G-6-P (0.7 urn) are added; the tube is mixed by
a vibrator and inserted in the fluorometer. In the
presence of G-6-P DII, G-6-P is converted to 6-PG
and TPN is reduced. For every molecule of G-6-P
converted to 6-PG, one molecule of TPN will be
reduced to TPNII. The fluorescence due to the
TPNH is recorded. The rate of formation of
TPNII is directly proportional to the concentra-
tion of G-6-P DII in the homogenate. The reac-
tion proceeds at a constant velocity for at least 3
minutes. This initial reaction velocity represents
the activity of the enzyme in 10 /Ll of homogenate
(one mg of epidermis) and is reported in the units
of mum of substrate (G-6-P) reacting per minute,
per mg of epidermis.(2) Phosphoglucomutase (PGM): 10 d of G-
1-P are added to 10 d of epidermal homogenate
with 1 cc of buffer. The PGM present in the epi-
dermal homogenate converts G-1-P to G-6-P.
G-6-P DR and TPN have also been added to this
reaction tube. As the G-6-P is formed it is im-
mediately transformed into 6-PG by the action of
G-6-P DII. TPN is reduced to TPNH and the
slope of the increase in TPNH concentration is a
measure of the enzyme activity.
(3) Hexokinase (ilK): The principle is the
same as that for G-6-P DII and PGM. Glucose
plus ATP (in the presence of Mg.) is converted
to G-6-P plus ADP by the action of the ilK pres-
* See Lowry et al J. B. C. J4: 1047, 1957. The
instrumentation used included a fluorometer (Far-
rand Model A2), a microammeter (RCA), and a
recording potentiometer (Photovolt varicord re-
corder).
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TPN (0.1 pm) X X X X X X X X X
G-6-P (0.7 pm) X x
G-1-P (0.7 pm) X X
G-6-P DII (0.1 units) X X X X X x x x
PGM (0.1 units) X X X
ATP (0.7 pm) X x
Glucose (0.55 pm) X x
TJTP (0.7 pm) X
UDPG DII (0.9 units) X X
DPN (0.5 pm) X X X
Glycogen (1.5 mg) X X
TJDPG (0.25 pm) X X
PEP (1 pm) x
PK (0.48 units) X
LDII (0.50 units) X
DPNH (0.1 pm) X
AMP (0.7 pm) X X
P04 (1.0 pm) X X
P-ase (1.5 units) X
ilK (0.1 units) x x
ent in the epidermal homogenate. Any G-6-P
formed is immediately turned into 6-PG by G-6-P
DII added to the reaction mixture. TPN is re-
duced to TPNH during this latter reaction, and
the rate of formation of TPNH is recorded.
(4) UDPG pyrophosphorylaze (IJDPG-PP):
This enzyme is responsible for the formation of
IJDPG from G-1-P and UTP (uridine triphos-
phate). [JDPG PP present in the epidermal ho-
mogenate converts UTP and G-1-P to EJDPG. Any
UDPG formed is immediately oxidized to TJDP-
glucuronic acid by the enzyme TJDPG dehydro-
genase in the presence of DPN. For every mole-
cule of UDPG transformed into UDP-glucuronic
acid, two molecules of DPN are reduced to
DPNII. The increase in DPNH fluorescence is
recorded.
(5) UDPG dehydrogenase (UDPG DII): This
assay is done by following the rate of formation of
DPNII from UDPG and DPN when homogenate
is added.
(6) Glycogen .synthetase (Gly Syn): This en-
zyme increases the length of the glycogen chain
by the addition of the glucose moiety of UDPG
onto glycogen. When acting with the branching
enzyme, it forms the tree-like structure of normal
glycogen. Glucose-6-phosphate is an activator of
this reaction and its exact role is not known. For
every molecule of glucose transferred to glycogen
one molecule of UDP is released. In the presence
of phosphoenolpyruvate (PEP) and pyruvic hi-
nase (PK) UDP is transformed into IJTP with
the simultaneous transformation of phosphoenol-
pyruvate into pyruvate. The pyruvate is immedi-
ately reduced in the presence of lactic dehydro—
genase to lactate. DPNH serves as the hydrogen
donor for this reduction and the reaction can be
assayed by the rate of disappearance of the fluo-
rescence due to DPNII.
(7) Phosphorylase (P-ase): Phosphorylase ca-
talyses the breakdown of glycogen to glucose-i-
phosphate. It can be assayed either in the direction
of glycogen breakdown or of glycogen formation.
We have assayed it in the direction of glycogen
breakdown to yield G-1-P. This reaction requires
the presence of inorganic phosphate. AMP is an
activator. The G-l-P formed by the breakdown of
glycogen is converted to G-6-P by phosphoglu-
comutase (PGM). Glucose-6-phosphate dehydro-
genase then converts the G-6-P into 6-PG with
the simultaneous reduction of TPN to TPNII.
The absolute amount of TPNH formed is directly
equal to the amount of G-1-P originally formed
from the glycogen. The rate of G-1-P formation
is then a measure of the activity of phosphorylase.
(8) Glucose4-phosphate (G-6-P): The concen-
tration of this substrate in the epidermal "acid
extract" is assayed by the addition of 10 pl of ex-
tract to 1 cc of buffer containing G-6-P DII and
TPN. The G-6-P present in the "acid extract"
will be transformed into 6-PG with the simulta-
neous reduction of TPN to TPNH. The absolute
amount of TPNH formed is a direct measure of
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the amount of G-6-P originally present in the
"acid extract" of the epidermis.
(9) Glucose-i-phosphate (G-1-P): The concen-
tration of this substrate is assayed by the addition
of PGM which will convert any G-1-P present in
the "acid extract" to G-6-P which is then ana-
lyzed as in the previous example.
(10) Uridine diphospho glucose (UDPG): The
amount of this substrate is assayed in the pres-
ence of IJDPG dehydrogenase, DPN, and "acid
extract." The amount of DPNH formed is twice
the amount of UDPG originally present in the
"acid extract."
(11) Glycogen: The estimation of glycogen in
tissue extracts by acid hydrolysis followed by
measurement of the resulting glucose has been
questioned. In this procedure, substances which
are not glycogen but which contain hydrolyzable
glucose will also contribute. In view of this, gly-
cogen has been assayed by the phosphorylase re-
action. The amount of glycogen present in the
"acid extract" is determined by the addition of
phosphorylase, AMP and inorganic phosphate.
Glycogen is broken down to form G-1-P. This
substance can be assayed as shown previously.
Since phosphorylase can only break down the
glycogen molecule until a branch point is reached,
only 40—50% of the glycogen molecule is degraded.
Under these circumstances, the amount of G-1-P
is approximately equal to one-half of the amount
of glycogen present and a suitable correction fac-
tor must be used.
(12) Glucose: Glucose is assayed in the "acid
extract" by conversion (in the presence of Mg',
ATP, and hexokinase) to G-6-P. The G-6.-P is then
determined as described previously.
(13) Adenosine triphosphate (ATP): ATP in
the "acid extract" is assayed by the use of the
hexokinase reaction, substituting glucose for ATP.
The amount of G-6-P formed by hexokinase will
be a direct measure of the amount of ATP pres-
ent in the added "acid extract." For every mole-
cule of G-6-P formed, one molecule of ATP will
have donated its terminal phosphate group to one
molecule of glucose.
RESULPS
The results of these assays are given in
Table II. All substrate concentrations are in
terms of mem/mg of fresh epidermis. All en-
zyme activities are in terms of mtm of sub-
strate transformed per minute per mg of epi-
dermis.
Figure 1 is a schematic picture of the cur-
rent concepts of glycogen formation and break-
down. Significant gaps in our knowledge exist
TABLE II
Enzymes
Activity (mpzn/min/mg fresh epidermis)
Room temp.
Average D. . Range
Presumed activity
at 370 C.
ilexokinase (iO)*
Phosphoglucomutase (9)
Glucose-6-phosphate dehydro-
genase (10)
UDPG Pyrophosphorylase (3)
Glycogen synthetase (4)
Phosphorylase (8)
UDPG dehydrogenase (11)
1.49±
1.01±
1.21±
0.66±
0.20±
0.36±
0.05±
0.32
0.25
0.23
0.01
0.02
0.11
0.02
0.70—2.02
0.67—1.42
0.86—1.47
0.64—0.67
0.17—0.22
0.23—0.53
0.01—0.08
3.0
2.02
2.42
1.32
0.40
0.72
0.10
Substrates
Concentration (mum/mg fresh epidermis)
Average S.D. Range
Glucose-i-phosphate (8)
Glucose-6-phosphate (8)
UDPG (11)
Glycogen (10)
ATP (9)
Glucose (11)
<0.10
<0.10
0.15±
2.6
465±
0.28±
1.25±
0.03
O.5t
88.6
0.07
0.36
0.10—0.21
1.8—3.5t
326—634
0.20—0.50
0.81—2.20
* Figures in parenthesis refer to the number of subjects.
f Concentration in mMm glucose equivalent/mg fresh epidermis.
Concentration in ms grams/mg fresh epidermis.
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GLYCOGENq/ \'
Olycogen SynThefcse/ \\
* Brcnching Enzyme!
UDP-GLUCURONATE
UDPtI Dehydrogenose
UDPG °°'!°
I ,Oebrcnching Enzyme
UOPG \. 1/
Pyrophosphorylose\\
IJTP+GLUCOSE -I-P
Phosphoglucomu lose
Hexo k/noseGLIJCOSE+ATP
Mgt" GLUCOSE-6-P+AQP
Fxo. 1
concerning branching and debranching en-
zymes.
The enzyme activities listed in Table II are
measured under optimum conditions of sub-
strate concentration and the absence of inhib-
iting substances and represent maximal in
vitro activities. These ideal circumstances do
not exist in viva. The in vivo enzyme reaction
rates are determined not only by the amount
of enzyme present (as measured by our in vitro
technics), but also by the actual substrate and
inhibitor concentrations within the tissue. The
greater the departure from the ideal conditions
used in the assay procedure, the smaller the
fraction of the maximal reaction rate which will
exist within the tissue.
The second part of Table II lists the actual
tissue concentrations of some of these sub-
strates and inhibitors. These values permit
some crude estimates of the in vivo activity
of the enzyme systems as compared with the
measured in vitro rates.
The Utilization of Glucose
Free glucose was found in the epidermis by
Schragger (8). This implies that the epider-
mal cell membrane poses no barrier to the
passage of glucose and does not limit the
utilization of glucose.
Hexokinase, the enzyme which phospho-
rylatea glucose to form G-6-P can convert 3.0
mm of glucose into G-6-P per minute/mg
of epidermis in vitro (Table II). Incubation
studies with epidermal slices indicate a rate of
glucose utilization of 0.5 mm/min/mg of epi-
dermis (9, 10). Therefore, in vivo hexokinase
is probably acting at about ¼th of its maxi-
mal activity. The substrate concentrations of
glucose and ATP (Table II) are not low
enough to explain this lack of activity. The
high intracellular ADP and phosphate concen-
trations, however, could be the inhibitors of
the hexokinase reaction (unpublished observa-
tion).
The Utilization of G-6-P
The concentration of glucose-6-phosphate is
extremely low in epidermis. Our more recent
measurements demonstrated a concentration of
0.06 m/hm/mg of epidermis which suggests that
those reactions which utilize G-6-P are very ac-
tive and efficient. These reactions certainly re-
move the 0.5 mm of G-6-P formed through
the hexokinase reaction. The enzymes which
utilize G-6-P as a substrate include: (1) phos-
phohexoseisom,erase (PHI) which forms fruc-
tose-6-phosphate (F-6-P) from G-6-P and initi-
ates glucose catabolism to lactic acid formation
(glycolysis) and to complete oxidation to CO2
and 1120 (Krebs cycle); (2) glucose4-phos-
phate dehydrogenase (G-6-PDH) which con-
verts G-6-P to 6-PG, the first step to ribose
phosphate for DNA and RNA synthesis; (3)
phosphoglucomutase (PGM) which converts
G-6-P to G-1-P and initiates the conversion of
glucose to UDPG and to the synthesis of the
uronic acids and glycogen; (4) glucose-6-phos-
phatase which splits G-6-P to free glucose and
inorganic phosphate. These enzymes compete
for the available glucose-6-phosphate which
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* Reaction rates in mym at substrate I mm / mg
** Estimated % of total 6-6-P directed along each pathway
Fic. 2
is being formed at a rate of approximately 0.5
mm/min/mg of epidermis.
In Figure 2, these pathways are shown dia-
grammatically with their relative reaction
velocities as measured in vitro. The reaction
rates of PHI and G-6-phosphatase are unpub-
lished observations on a few samples of epi-
dermis.
From the work of Freinkel (10), 75% of the
G-6-P is converted to F-6-P by PHI. This
is obviously the major pathway of glucose-6-
phosphate utilization.
Glycogen synthesis depends upon the amount
of G-1-P which is formed from the available
G-6-P by PGM. The enzyme activity of PGM
is approximately equal to that of G-6-P DII
(which converts an estimated 5% of the G-6-P
to 6-PG (10)). Since G-1-P is present in very
low concentrations and would therefore not
inhibit PGM, the amount of G-6-P converted
to G-1-P would also be about 5% of the avail-
able G-ea-P or about 0.025 mjm of G-l-P
formed per minute per milligram of epidermis.
The remaining pathway is that of G-6-phos-
phatase, a hitherto biochemically unrecog-
nized reaction in skin. By subtraction of the
percent utilization by the routes already con-
sidered, about 15% of the G-6-P is broken
down to form free glucose. Since G-6-phos-
phatase (in vitro rate of 6.0 mm/min/mg) is
3 times as active as PGM or G—6-P DII and
one-fourth as active as PHI, this pathway
might be expected to account for about 15% of
the G-6-P utilization on the basis of relative
enzyme activities also.
The Utilization of G-1-P
Glucose-i-phosphate, formed from G-6-P by
the action of phosphoglucomutase, must be
utilized immediately since it has a low tissue
concentration. Our recent measurements indi-
cate a tissue concentration of 0.01 mjm/mg. The
enzyme responsible for the utilization of G-1-P,
UDPG pyrophosphorylase (TJDPG PP), is
present in large excess (50 times the amount
necessary to convert 0.025 m/Lm/min of G-1-P
into TJDPG along this pathway). This large
excess of UDPG PP is probably necessary to
prevent the reversal of the PGM reaction which
would result in net synthesis of G-6-P rather
than G-l-P. The product of the UDPG PP
reaction, UDPG, has an appreciable tissue
concentration which would tend to reverse the
reaction, that is, backward to the formation
of G-1-P rather than to IJDPG formation.
Knowledge of the concentrations of UTP and
pyrophosphate, the other two substrates taking
part in the 1JDPG PP reaction, would further
define this reaction.
The Utilization of UDPG
The rate of formation of UDPG has been
estimated to be about 0.025 mtm/min/mg of
epidermis (same as G-1-P formation). Two
pathways utilize this substrate (Figure 1): (1)
to uronic acid formation, catalyzed by the en-
zyme UDPG DII; and (2) to glycogen forma-
tion catalized by glycogen synthetase. The ac-
tivity of glycogen synthetase is four times that
of UDPG DII (Table II). Therefore, most of
the UDPG would be expected to be channeled
into glycogen formation. In addition, the reac-
tion toward glycogen formation is essentially
irreversible while the reaction to uronic acid
formation is reversible. This would also favor
the formation of glycogen from UDPG. The
majority of the 0.025 m/km/min of UDPG
formed must then be directed into glycogen
synthesis.
The Formation and Breakdown
of Glycoqen
In vivo epidermal glycogen is normally
maintained at a stable concentration (465
mjg/mg of epidermis), therefore, the amount
of glycogen being formed each minute must
equal the amount being destroyed, and glyco-
G.l.p 5%**
2.0*JPGM0-6-Phospho/ose 6-6-P Oh'GLUCOSE G-6-P - 6-PG
15% 6.0 4 2.4
24.0 JPH/
F-6-P 75%
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gen synthetase activity must equal phos-
phorylase activity. The amount of glycogen
being formed from UDPG per minute is ap-
proximately 5% of the glucose-6-phosphate
used or 0.025 mm/mg. The in vitro activities
of these two enzymes are, however, 16 times
greater in the case of glycogen synthetase and
28 times greater in the case of phosphorylase.
The assessment of the factors which in-
hibit the in vivo reaction rates is difficult due
to the complex nature of these reactions. Some
of the in vivo controlling factors indicated in
other tissues include: (1) The G-6-P concen-
tration of the tissue. This substance inhibits
phosphorylase while activating glycogen syn-
thetase. The extremely low concentration of
this substance in epidermis makes it unlikely
to be a limiting factor; (2) AMP which ac-
tivates phosphorylase is present in the in vitro
assay. The AMP concentration is not known
in the epidermis, however; (3) the phosphate
concentration of the tissue. This substance is
necessary for the phosphorylase reaction to
occur, but quantitative data on its effects on
epidermal phosphorylase are not available.
In addition to the above considerations, reac-
tion rates of branching and debranching en-
zymes are unknown as are the factors which
control these enzymes. These reactions may be
slower than the synthetase and phosphorylase
reactions.
Other Routes of Glycogen Breakdown
Many tissues contain amylases of various
types which may degrade glycogen to oligosac-
charides and then to glucose by means of vari-
ous amylo-1 ,4-glucosidases. A glucosidase which
acts at neutral pH has been found in rat liver,
but has not been found in human liver. Both
human tissues and rat liver contain a maltase or
amylo-1 ,4-glucosidase which acts in acid PH,
possibly associated with lysosomes (11).
Two attempts were made to demonstrate
significant degradation of glycogen to glucose
without the involvement of phosphorylase at a
neutral pH. Such activity was demonstrable
but was exceedingly low, about Mo the activity
of phosphorylase. This pathway is not believed
to be of quantitative importance in normal
glycogen degradation. We have not examined
our preparations for the presence or absence
of a lysosomal "acid maltase."
The Effect of Intracellular Organization
One facet not considered in this type of
study is the special localization of the enzymes
and substrates. In liver, for instance, glyco-
gen synthesis and breakdown occurs on a spe-
cial organelle, and the enzymes and substrates
are not mingled in a homogenous system at any
time. The concentration data reported here
were derived from epidermal homogenates and
may not reflect the actual intracellular state.
Although the concentration of a substance
within the whole cell may be very small, the
concentration within the organelle where it is
active may be rather high. G-1-P, for instance,
may be concentrated upon a "glyeogen or-
ganelle" and its total intracellular concentra-
tion may be very small. If such were the case,
a higher G-1-P concentration would slow down
the phosphoryla.se reaction and would aLso favor
the formation of UDPG and glycogen.
SUMMARY AND CONCLUSIONS
Data on substrate concentrations and on
the maximal activities of several enzymes in-
volved in glucose metabolism and glycogen
formation and breakdown have been presented.
These represent an initial step towards an un-
derstanding of the formation and breakdown
of glycogen.
Our findings combined with those of other
workers indicate that glucose within the cell
is converted (at approximately 0.5 mm/min/
mg epidermis) by hexokinase to glucose-6-phos-
phate. The rate of this reaction is controlled
mainly by the tissue concentration of ADP and
inorganic phosphate.
The glucose-6-phosphate is utilized by four
different enzymes. Approximately 75% is con-
verted to fructose-6-phosphate, 5% to 6-phos-
phogluconate, 5% to G-1-P and UDPG, and
about 15% is broken down to free glucose.
Of the 5% (0.025 mm/min/mg) going to
UDPG formation, the majority proceeds to
glycogen formation and only a fraction is
channeled into uronic acid formation. Glyco-
gen synthesis (by glycogen synthetase) and
its breakdown (by phosphorylase) presumably
occur at equal rates which maintains the tis-
sue concentration of glycogen at about 465
mpg/mg. These enzymes of glucose metabolism
are found in epidermis in much greater con-
centrations than those necessary to reproduce
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in vivo reaction rates. Some of the possible
reasons for the differences between the in vivo
rates and the in vitro rates were discussed.
Glycogen formation and breakdown in epi-
dermis seems to be an active process, with the
potentiality of even greater activity (based
on the enzyme activities measured). Compari-
son of these data with similar data from patho-
logical and experimental situations should yield
valuable clues to the mechanisms which control
these enzymes.
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